Showing results (41-50 of 53) with videos related to
Sort By:
Pageof 6
Scientific Reports|March 19, 2021
Suppressor of cytokine signaling-1 mimetic peptides attenuate lymphocyte activation in the MRL/lpr mouse autoimmune modelJatin Sharma, Teresa D Collins, Tracoyia Roach, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 23, 2025
Virtual crossmatching: Principles, practices, and the path forward-An American Society for Histocompatibility and Immunogenetics/College of American Pathologists collaborativeH Cliff Sullivan, Andrés Jaramillo, Sujata Gaitonde, et al.Open Forum Infectious Diseases|May 20, 2025
Dolutegravir/Abacavir/Lamivudine in Acute HIV-1 Results in Rapid Suppression and Restoration of CD4 T-cell Subsets Without Accelerated Decay of Latent HIV-1Cynthia L Gay, Jessica Keys, JoAnn D Kuruc, et al.Mbio|September 22, 2022
Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) StudyLuther A Bartelt, Alena J Markmann, Bridget Nelson, et al.Science Immunology|June 13, 2020
The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patientsLakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, et al.Mbio|September 30, 2020
SARS-CoV-2 Seroprevalence among a Southern U.S. Population Indicates Limited Asymptomatic Spread under Physical Distancing MeasuresAmir Barzin, John L Schmitz, Samuel Rosin, et al.Msphere|August 25, 2021
Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent IndividualsAlena J Markmann, Natasa Giallourou, D Ryan Bhowmik, et al.Medrxiv : the Preprint Server for Health Sciences|February 10, 2021
Sex disparities and neutralizing antibody durability to SARS-CoV-2 infection in convalescent individualsAlena J Markmann, Natasa Giallourou, D Ryan Bhowmik, et al.Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
The RBD Of The Spike Protein Of SARS-Group Coronaviruses Is A Highly Specific Target Of SARS-CoV-2 Antibodies But Not Other Pathogenic Human and Animal Coronavirus AntibodiesLakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, et al.Human Immunology|July 2, 2019
HLA alleles and haplotypes observed in 263 US familiesKazutoyo Osoegawa, Kalyan C Mallempati, Sridevi Gangavarapu, et al.Pageof 6